6 (download XLSX Statistical source data for Extended Data Fig
Safety, Risks and Guidance Mounjaro is the brand name for tirzepatide, a prescription medicine used under clinical supervision
In landmark SURMOUNT trials, participants on tirzepatide injection lost an average of 5 to 8 pounds in the first month, with losses accelerating in months 2 and 3
Consult Your Healthcare Provider Contact your clinician if nausea prevents adequate eating or drinking, or if you see warning signs like high fever, severe abdominal pain, blood in vomit or stool, or prolonged vomiting beyond 24 hours
It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking a hormone that helps regulate blood sugar levels in the intestines